Delivery Order SPE2DB22D2211-SPE2DB25FRUZS

Award Date 4/10/25
Potential Completion Date 4/11/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,488.84, is for the supply of 4567062416 - Levocetirizine 2.5 mg/5 ml solution, 148 ml, with a period of performance through January 28, 2025. This contract represents a small portion of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,202.44, is for the delivery of 4564840964 - Levocetirizine 5 mg Tablets in 90-count packages. The award is a firm fixed-price delivery order with a completion date of June 10, 2024. Amerisourcebergen is a major pharmaceutical distribution company that has been awarded several federal contracts to supply a wide range of medications and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,158.96 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which runs through February 2024, is for the supply of 4,563,713,933 units of Cetirizine HCl 10 mg tablets. This award is part of a larger $999,999,999 IDC between Amerisourcebergen and the DLA, which serves as a primary vehicle for...
This federal contract award, valued at $1,224.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,796,218 units of Cetirizine HCL 10 mg tablets, with a completion date of April 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,506.92 firm fixed-price delivery order is for the supply of 4,563,957,965 Cetirizine HCL 5 mg tablets, with a performance period through March 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,046.97 firm fixed-price delivery order is for the supply of 4,567,707,523 units of Cetirizine HCL 10 mg tablets, with a performance period through March 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $59,665.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,558,426,748 units of the pharmaceutical product Cetirizine HCL 5 mg Tablet in 100-count bottles. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,568.90, is a delivery order for the supply of Cetirizine HCL 10 mg tablets. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
The federal contract award is for the delivery of 4,567,154 units of Cetirizine HCL 5 mg tablets in 100-count packages. The contract, valued at $1,121.39, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a firm fixed-price pricing type and a completion date of February 5, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Cetirizine HCL 1 mg/ml solution, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $23,781.84 and is a firm fixed price delivery order with a completion date of May 13, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRUZS
    Delivery Order

This federal contract award, valued at $1,503.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,869,058 units of LEVOCETIRIZINE 2.5 MG/5 ML SOL 148ML, a pharmaceutical product.

The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This allows Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

The contract award is not designated as a set-aside, indicating open competition. The pricing type is Firm Fixed Price, and the ultimate completion date is April 11, 2025.

Generated 7/17/25, 6:22 PM